Search
Searching Content indexed under Food and Drugs Law by Deloitte ordered by Published Date Descending.
Links to Result pages
 
1 2  
>>Next
 
Title
Country
Organisation
Author
Date
1
Digital Transformation In Biopharma: Time For A Sea Change In Strategy
Deloitte recently conducted a survey with the MIT Sloan Management Review to assess the digital maturity of companies across a wide variety of industries.
UK
1 Nov 2018
2
Fighting The Opioid Crisis – A UK Perspective
By now, it is likely that most people have heard about the ongoing opioid crisis in the US, as barely a day goes by without some form of media coverage.
UK
9 Oct 2018
3
World Alzheimer's Day
In the late 1970s, Earth, Wind & Fire released one of their biggest hits – September – with an opening line that has become an internet meme and is widely recognised around the world.
UK
3 Oct 2018
4
Tackling Counterfeit Medicines In India
India is one of the leading global producers of low-cost generic medicines due to its high domestic demand and inexpensive manufacturing costs.
UK
12 Apr 2018
5
A New Future For R&D? Applying Emerging Technologies To Improve R&D Productivity
In December, we published our eighth annual report on Measuring the return from pharmaceutical innovation. This series of reports tracks the annual return on investment (ROI) ...
UK
22 Jan 2018
6
A New Future For R&D?
The pharmaceutical industry continues to face an extremely challenging R&D environment and has yet to turn a corner in terms of its R&D value proposition.
UK
5 Jan 2018
7
Pharma And The Connected Patient: A Patient's View
Last month we published our report ‘Pharma and the connected patient: How digital technology is enabling patient centricity'...
UK
10 Aug 2017
8
Pharma And The Connected Patient: How Digital Technology Is Enabling Patient Centricity
This week we launched our report Pharma and the connected patient: How digital technology is enabling patient centricity.
UK
7 Aug 2017
9
Pharma And Emerging Markets: Unlocking The Potential Of Emerging Economies
Just a few years ago, slowing growth in the US and European pharmaceutical markets led many multinational pharmaceutical companies to seek new forms of growth in emerging markets.
UK
13 Jul 2017
10
Priorities For R&D leaders: Innovation And Collaboration
This week marks the release of our first annual survey of pharmaceutical R&D leaders: Innovating to survive, collaborating to thrive.
UK
7 Jun 2017
11
Spring Budget 2017 Analysis - Tobacco Duty And Minimum Excise Tax
As announced in Budget 2014, duty rates on all tobacco products will increase by 2 per cent above retail price ideas inflation.
UK
9 Mar 2017
12
Defining A Drug's Value: Is Beauty In The Eye Of The Beholder?
Many health plans are raising the bar for value as they try to rein in drug spending.
UK
15 Feb 2017
13
Brewery To Bar: Innovation In Diageo's Supply Chain
Whilst enjoying a creamy pint of draft Guinness, have you ever wondered about its journey from brewery to bar.
UK
15 Nov 2016
14
Brewery To Bar: Innovation In Diageo's Supply Chain
Whilst enjoying a creamy pint of draft Guinness, have you ever wondered about its journey from brewery to bar? The famous black stuff is available in 100 countries worldwide and is brewed in almost 50.
UK
9 Nov 2016
15
The Cost Of Unused Medicines In The UK
April 30th is National Take Back Day in the US. Take back events encourage consumers/patients to return unused medicines that are lying around their homes to pharmacies, so that they can be disposed of properly.
UK
3 May 2016
16
How Healthy Is Pharmaceutical Research And Development (R&D)?
In December 2015 we launched our sixth annual report on ‘Measuring the return from pharmaceutical innovation'.
UK
17 Mar 2016
17
Can New Diagnostic Tests Help Tackle Antibiotic Resistance?
Antibiotics, first prescribed in the mid-1940s, have for many years been seen as the magic bullet to treat infections.
UK
2 Feb 2016
18
Measuring The Return From Pharmaceutical Innovation 2015: Transforming R&D Returns In Uncertain Times
Welcome to the sixth annual Deloitte report exploring the pharmaceutical industry's performance in generating a return from its significant annual investment in new product innovation.
UK
19 Jan 2016
19
A Personal Take On Measuring Pharma R&D Returns
You may have seen the headlines this week that pharma R&D returns are at their lowest level for at least 5 years.
UK
30 Dec 2015
20
Taking A Scalpel To Global Drug Access And Affordability
While infectious disease burden is still a pressing issue around the world, many regions are also facing an explosion of the same chronic and lifestyle diseases that are impacting the developed world.
United States
23 Nov 2015
Links to Result pages
 
1 2  
>>Next